SEC FORM 4
$0.00
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Acquisition (code A) of 5,000 shares at $0 per share.
Reporting Person Ambrose Kristen · Officer Title SVP & Chief Accounting Officer · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0000875320-26-000267 · filed 2026-09-01 · View filing →
